Evidence map›Paper›PMID 32425948›Full record

ArticleFrontiers in immunology2020

AID Overlapping and Polη Hotspots Are Key Features of Evolutionary Variation Within the Human Antibody Heavy Chain (IGHV) Genes.

Catherine Tang, Davide Bagnara, Nicholas Chiorazzi, Matthew D Scharff, Thomas MacCarthy

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Molecular genetic aberrations in the pathogenesis of multiple myeloma.Asian biomedicine : research, reviews and news · 2023
    Review
  15. Article
  16. Article
  17. Promoter Proximity Defines Mutation Window for VJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  18. Article
  19. Article
  20. The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Catherine TangDepartment of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, United States.
Davide BagnaraKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, United States.
Nicholas ChiorazziKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, United States.
Matthew D ScharffDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, United States.
Thomas MacCarthyDepartment of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, NY, United States.
Stony Brook University · USAlbert Einstein College of Medicine · USFeinstein Institute for Medical Research · USNorthwell Health · US

Funding

A combined computational and experimental approach to the evolution and role of the DNA sequence environment in targeting mutations to antibody V regionsR01AI132507 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI RIZZO, ROBERT C., SCHARFF, MATTHEW D · 2018 to 2022
$3.0M
High-throughput informatics for antibodiesR01GM111741 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MACCARTHY, THOMAS · 2015 to 2018
$1.1M
NIAID NIH HHS R01 AI132507NIGMS NIH HHS R01 GM111741
6 · The paper itself

Abstract

Somatic hypermutation (SHM) of the immunoglobulin variable (IgV) loci is a key process in antibody affinity maturation. The enzyme activation-induced deaminase (AID), initiates SHM by creating C → U mismatches on single-stranded DNA (ssDNA). AID has preferential hotspot motif targets in the context of WRC/GYW (W = A/T, R = A/G, Y = C/T) and particularly at WGCW overlapping hotspots where hotspots appear opposite each other on both strands. Subsequent recruitment of the low-fidelity DNA repair enzyme, Polymerase eta (Polη), during mismatch repair, creates additional mutations at WA/TW sites. Although there are more than 50 functional immunoglobulin heavy chain variable (IGHV) segments in humans, the fundamental differences between these genes and their ability to respond to all possible foreign antigens is still poorly understood. To better understand this, we generated profiles of WGCW hotspots in each of the human IGHV genes and found the expected high frequency in complementarity determining regions (CDRs) that encode the antigen binding sites but also an unexpectedly high frequency of WGCW in certain framework (FW) sub-regions. Principal Components Analysis (PCA) of these overlapping AID hotspot profiles revealed that one major difference between IGHV families is the presence or absence of WGCW in a sub-region of FW3 sometimes referred to as "CDR4." Further differences between members of each family (e.g., IGHV1) are primarily determined by their WGCW densities in CDR1. We previously suggested that the co-localization of AID overlapping and Polη hotspots was associated with high mutability of certain IGHV sub-regions, such as the CDRs. To evaluate the importance of this feature, we extended the WGCW profiles, combining them with local densities of Polη (WA) hotspots, thus describing the co-localization of both types of hotspots across all IGHV genes. We also verified that co-localization is associated with higher mutability. PCA of the co-localization profiles showed CDR1 and CDR2 as being the main contributors to variance among IGHV genes, consistent with the importance of these sub-regions in antigen binding. Our results suggest that AID overlapping (WGCW) hotspots alone or in conjunction with Polη (WA/TW) hotspots are key features of evolutionary variation between IGHV genes.

Indexed as

Evolution, MolecularAICDA (Activation-Induced Cytidine Deaminase)Complementarity Determining RegionsCytidine DeaminaseDNA-Directed DNA PolymeraseHumansImmunoglobulin Heavy ChainsMutationY-Family DNA PolymerasesAICDA (Activation-Induced Cytidine Deaminase)Complementarity Determining RegionsCytidine DeaminaseDNA-Directed DNA PolymeraseImmunoglobulin Heavy ChainsRad30 proteinY-Family DNA Polymerasesactivation induced deaminase (AID)B cell receptor (BCR)computational immunologydimensionality reductionimmunoglobulin heavy chainsomatic hypermutation (SHM)unsupervised learning

Identifiers

PMID32425948
PMCPMC7204545
OpenAlexW3021143157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.